TARMIQRA Trademark

Trademark Overview

On Friday, April 4, 2014, a trademark application was filed for TARMIQRA with the United States Patent and Trademark Office. The USPTO has given the TARMIQRA trademark a serial number of 79146282. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, April 5, 2024. This trademark is owned by IPSEN PHARMA S.A.S. The TARMIQRA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the prevention, treatment, and cure of oncological, endocrine, neurological, hematological, gastroenterological, and urological conditions and diseases and for the prevention, treatment, and cure of cardiovascular and cognitive disorders
tarmiqra

General Information

Serial Number79146282
Word MarkTARMIQRA
Filing DateFriday, April 4, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, April 5, 2024
Registration Number4623099
Registration DateTuesday, October 21, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 5, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the prevention, treatment, and cure of oncological, endocrine, neurological, hematological, gastroenterological, and urological conditions and diseases and for the prevention, treatment, and cure of cardiovascular and cognitive disorders
Translation of Words in MarkThe wording "TARMIQRA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIPSEN PHARMA S.A.S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party NameIPSEN PHARMA S.A.S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressF-92100 BOULOGNE BILLANCOURT
FR
Party NameIPSEN PHARMA S.A.S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressF-92100 BOULOGNE BILLANCOURT
FR

Trademark Events

Event DateEvent Description
Friday, May 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 6, 2014APPLICATION FILING RECEIPT MAILED
Friday, May 23, 2014REFUSAL PROCESSED BY IB
Thursday, May 1, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 5, 2014ASSIGNED TO EXAMINER
Tuesday, May 6, 2014NON-FINAL ACTION WRITTEN
Wednesday, May 7, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, May 7, 2014REFUSAL PROCESSED BY MPU
Wednesday, May 7, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 1, 2014NOTIFICATION PROCESSED BY IB
Thursday, June 12, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 23, 2014ASSIGNED TO LIE
Wednesday, June 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 25, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 1, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 16, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 16, 2014NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 16, 2014NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 21, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 20, 2015FINAL DISPOSITION PROCESSED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 5, 2014PUBLISHED FOR OPPOSITION
Tuesday, August 5, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 21, 2014REGISTERED-PRINCIPAL REGISTER
Friday, March 20, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 10, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, March 1, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 9, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 21, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, March 10, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 10, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, March 10, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, March 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 10, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, March 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, May 13, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 9, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, July 11, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Friday, June 19, 2020REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Friday, May 7, 2021CANCELLED SECTION 71
Friday, January 7, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, May 9, 2022INVALIDATION PROCESSED
Friday, October 18, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, October 18, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

tarmiqra treatment prevention cure diseases conditions cardiovascular cognitive urological disorders neurological